References
- 1
Pasricha P J, Ravich W J, Hendrix T R. et al .
Treatment of achalasia with intrasphincteric injection of botulinum toxin: a pilot
trial.
Ann Intern Med.
1994;
121
590
- 2
Pasricha P J, Ravich W J, Hendrix T. et al .
Intrasphincteric botulinum toxin for the treatment of achalasia.
N Engl J Med.
1995;
332
774
- 3
Cuilliere C, Ducrotte P, Zerbib F. et al .
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum
toxin.
Gut.
1997;
41
87
- 4
Rollan A, Gonzalez R, Carvajal S, Chianale J.
Endoscopic intrasphincteric injection of botulinum toxin for the treatment of achalasia.
J Clin Gastroenterol.
1995;
20
189
- 5
Fishman V M, Parkman H P, Schiano T D. et al .
Symptomatic improvement in achalasia after botulinum toxin injection of the lower
esophageal sphincter.
Am J Gastroenterol.
1996;
91
1724
- 6
Kolbasnik J, Waterfall W E, Fachnie B. et al .
Long-term efficacy of botulinum toxin in classical achalasia: a prospective study.
Am J Gastroenterol.
1999;
94
3434
- 7
Annese V, Bassotti G, Coccia G. et al .
A multicentre randomised study of intrasphincteric botulinum toxin in patients with
oesophageal achalasia.
Gut.
2000;
46
597
- 8
Wehrmann T, Schmitt T, Dietrich C F. et al .
Manometrically-guided endoscopic injection of botulinum toxin for esophageal achalasia:
a pilot trial.
Z Gastroenterol.
2000;
38
899
- 9
Hoffman B J, Knapple W L, Bhutani M S. et al .
Treatment of achalasia by injection of botulinum toxin under endoscopic ultrasound
guidance.
Gastrointest Endosc.
1997;
45
77
- 10
Annese V, Bassotti G, Coccia G. et al .
Comparison of two different formulations of botulinum toxin A for the treatment of
oesophageal achalasia. The Gismad Achalasia Study Group.
Aliment Pharmacol Ther.
1999;
13
1347
- 11
Preiksaitis H G, Diamant N E.
Regional differences in cholinergic activity of muscle fibers from the human gastroesophageal
junction.
Am J Physiol.
1997;
272 (6 Pt 1)
G1321-7
- 12
Annese V, Basciani M, Perri F. et al .
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilatation
in achalasia.
Gastroenterology.
1996;
111
1418
- 13
Vaezi M F, Richter J E, Wilcox C M. et al .
Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: A randomized
trial.
Gut.
1999;
44
231
- 14
Prakash C, Freedland K E, Chan M F, Clouse R E.
Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy
of a single pneumatic dilatation: a survival analysis approach.
Am J Gastroenterol.
1999;
94
328
- 15
Allescher H D, Storr M, Gonzales-Donoso R. et al .
Treatment of achalsia: botulinum toxin injection vs. pneumatic balloon dilatation.
A prospective study with long-term follow-up.
Endoscopy.
2001;
33
1007
- 16
Imperiale T F, O'Connor J B, Vaezi M F, Richter J E.
A cost-minimization analysis of alternative treatment strategies for achalasia.
Am J Gastroenterol.
2000;
95
2737
- 17
Panaccione R, Gregor J C, Reynolds R P, Preiksaitis H G.
Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost
minimization analysis.
Gastrointest Endosc.
1999;
50
492
- 18
Urbach D R, Hansen P D, Khajanchee Y S, Swanstrom L L.
A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller
myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation,
or botulinum toxin injection.
J Gastrointest Surg.
2001;
5
192
P. J. Pasricha, M.D.
Division of Gastroenterology and Hepatology · University of Texas Medical Branch
4.106 McCullough Building - Rt. 0764 · 301 University Boulevard · Galveston, TX 7755-0764
Fax: + 1-409-772-4789
eMail: jpasrich@utmb.edu
